Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.
- Conditions
- Peripartum Cardiomyopathy
- Registration Number
- NCT04927715
- Lead Sponsor
- Sohag University
- Brief Summary
this is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism in female patients with peripartum cardiomyopathy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
- This study will include females aged between 18 and 45 years old who have been diagnosed and treated clinically for peripartum cardiomyopathy
Exclusion Criteria
- Age less than 18 or more than 45 year old
- females with dilated cardiomyopathy due to other etiology or outside the time frame of occurrence of peripartum cardiomyopathy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Irisin level 4 months detect the serum level of irisin hormone by ELIZA in nanogram/decilitre(ng/dl)
FNDC5 Genotyping 4 months whether homogenetic or heterogenetic
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag uniersity hosoital
🇪🇬Sohag, Egypt